Abdominal & Pelvis Pain
A19-year-old female with no past medical history presents with right-sided lower abdominal pain for 2 years.
Implementation of systematic screening for anxiety, disability and pain in children aged 8 to 18 years presenting with abdominal pain at a gastroenterology division of a large medical center resulted in an increase in screening rates and psychological referrals.
A 2-week course of treatment with rifaximin for diarrhea-predominant irritable bowel syndrome was found to improve abdominal pain symptoms.
Similar reductions were seen for most bothersome symptom severity for all treatment groups over 12 weeks (estradiol, −1.4; moisturizer, −1.2; and placebo, −1.3).
Trigger point injection with steroids and pulsed radiofrequency treatment of trigger points may effectively relieve pain associated with abdominal myofascial pain syndrome.
Lumbopelvic pain in well-functioning older adults was found to be associated with greater walking-related energy expenditure and reduced walking endurance compared with individuals without lumbopelvic pain.
Lateral Cutaneous Nerve Entrapment Syndrome, a newly defined syndrome characterized by flank tenderness, may successfully be treated with lidocaine injections and alternative treatments.
Public-private partnership initiative develops core diagnostic criteria for abdominal, pelvic, and urogenital pain associated with irritable bowel syndrome.
Treatment with elagolix was associated with sustained reduction in average monthly dysmenorrhea and non-menstrual pelvic pain through a 12-month treatment period.
A flexible extended regimen of 20 mg ethinylestradiol and 3 mg drospirenone (FlexibleMIB) was shown to be superior to placebo for reducing endometriosis-related pain.
Long-term exposure to progestin-only oral contraceptives or to a progestin intrauterine device is associated with a small beneficial effect on pelvic girdle pain.
Neurostimulation through percutaneous electrical nerve field stimulation was shown to durably reduce pain in children.
A polyethylene glycol low-volume regimen is noninferior to a high-volume regimen for colon cleansing in patients with inflammatory bowel disease.
Trigger point injection as an adjunct to physical therapy is well tolerated and improves symptoms of pelvic floor muscle spasm in approximately 50% of patients with chronic prostatitis/chronic pelvic pain syndrome.
The FDA has accepted the supplemental New Drug Application for Trulance for the treatment of irritable bowel syndrome with constipation.
The efficiency of self-administered hypnotherapy is equivalent to that of in-office hypnotherapy in relieving pediatric irritable bowel syndrome or functional abdominal pain.
At 3 months, significantly more women receiving both doses of elagolix had reductions in dysmenorrhea and nonmenstrual pelvic pain compared with those receiving placebo.
Probiotics may alleviate pain in the short-term in children with recurrent abdominal pain.
The FDA is warning patients and healthcare professionals that Viberzi tablets should not be used in patients without a gallbladder due to an increased risk of developing serious pancreatitis
Treatment with the high-concentration capsaicin patch was safe and effective for improving pain in patients with chronic pelvic, perineal, and gluteal neuralgia pain.
Most frequent upper functional GI disorders in IBS were functional dyspepsia, belching disorders
Tighter clustering of controls versus wider clustering of cases in UniFrac principal coordinate analysis
Two cases reported of seniors with atypical presentation, including nonspecific symptoms
Tarantula toxin specifically mediates mechanonociception
Randomized trial shows significant pain reduction for patients with chronic calcific pancreatitis.
Image-guided testing of tissue from the renal mass may lead to improved treatments, researchers say.
Review shows reduced recurrence rates for dysmenorrhea with continuous versus cyclic schedule.
More than half of elective resections done after fewer than three preceding episodes.
Case report describes 85-year-old man who presented twice with fever and painful erythema.
Medication was approved recently by the US Food and Drug Administration.
Researchers also report growing number of cases among women and children.
Clinical Pain Advisor Articles
- Replacing Sleep, Sedentary Behavior With Physical Activity Beneficial in Knee Osteoarthritis
- The Role of Psychological Factors in Phantom Limb Pain Reviewed
- FDA Outlines Plan for New Analgesic Guidance to Combat Opioid Crisis
- Ozone vs Corticosteroids May Provide Longer-Lasting Effects for Plantar Fasciitis
- Opioid Use Stable in Past Decade Among Commercially Insured, Medicare Beneficiaries
- Ketamine: Mechanisms of Action, Uses in Pain Medicine, and Side Effects
- Cannabis May Be Effective for Migraine Treatment
- Medicinal Cannabis May Not Have Opioid-Sparing Effects in Chronic Noncancer Pain
- Integrating Psychological Interventions Into Chronic Pain Management
- Chronic Neck Pain: Generators, Clinical Examination, MRI Findings, and Differential Diagnosis
- Pregabalin May Not Improve Analgesia During Medical Abortion
- Investigational Treatment Shows Promise in Chronic Low Back Pain
- Rheumatologist-Assessed vs Criteria for Inflammatory Back Pain in Psoriatic Arthritis
- Incorporating Guidelines Into Clinical Practice: An Interview With Gary L. LeRoy, MD
- Pain Severity May Partly Mediate the Association Between Depression and Physical Performance in Knee OA